CXCR4 and prostate cancer: Meta-analysis of studies of CXCR4 expression in multiple cancers including prostate cancer, non-small cell lung cancer, pancreatic ductal adenocarcinoma and others concluded that CXCR4 expression is associated with a poor prognosis and lower overall survival [13-16].